Mayne Pharma Group Ltd
ASX:MYX
Mayne Pharma Group Ltd
ASX:MYX
Price:
7.12 AUD
-0.28%
Market Closed
Updated:
May 10, 2024
Mayne Pharma Group Ltd
Income to Minority Interest
|
Mayne Pharma Group Ltd
Income to Minority Interest Peer Comparison
Comparables:
RCE
NEU
BOT
PBP
C
CU6
Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income to Minority Interest | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Income to Minority Interest
AU$92k
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Probiotec Ltd
ASX:PBP
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mayne Pharma Group Ltd's Income to Minority Interest?
Income to Minority Interest
92k
AUD
92k
AUD
Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Income to Minority Interest amounts to 92k AUD.
What is Mayne Pharma Group Ltd's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 5Y
-20%
-20%
Over the last year, the Income to Minority Interest growth was -99%. The average annual Income to Minority Interest growth rates for Mayne Pharma Group Ltd have been -63% over the past three years , -20% over the past five years .
You don't have any saved screeners yet
